The Fibroids Miracle along with your Wellness
During the past few years, many individuals are speaking about Fibroids Miracle and publishing Fibroids Miracle testimonials on this controversial strategy which was designed to eradicate uterine fibroids right away. The reason that this plan is so controversial in many peoples heads is really because it claims to wholly heal and eliminate uterine fibroids for good without surgery or allotropic medication. It's an totally all-natural and holistic method of healing this serious issue that causes a lot of women both discomfort and pain. Every day, new Fibroids Miracle articles are being posted claiming how powerful the natural method to eliminating these uterine fibroids really is. Lots of women who've utilized the program and seen final resu ...

Uterine Fibroids: About Fibroids, Symptoms and Treatment Options
The exact cause of uterine fibroids isn't known, but they are common among many women in their 30s and 40s. African American women are at a higher risk of developing fibroids, and approximately 80 percent will do so at some point in their lives. However, only 10 to 20 percent of women with fibroids will develop symptoms, and it's possible to live with fibroids, never knowing of their existence.

African American Women and Infertility: An Unmet Need
ATLANTA, April 2, 2012 /PRNewswire/ -- Infertility affects one in eight couples or 7.3 million people in the U.S.  12% of women of reproductive age experience difficulty having a baby and black women have twice the odds of infertility compared to white women.  11.5% of black women report infertility compared to 7% of white women but yet studies indicate that black women use infertility services less often.  Why?  "In the past, there was a lack of attention toward the problem of infertility in minority women, and most marketing campaigns of infertility awareness and treatment were not directed towards us.  This resulted in a lack of awareness about infertility as a disease and about avenues for seeking evaluation and treatment," says Dr.

American Capital and its Affiliates Invest $20 Million in Portfolio Company Halt Medical
BETHESDA, Md., March 13, 2012 /PRNewswire/ -- American Capital, Ltd. (Nasdaq: ACAS) announced today that it has invested $11.7 million, $20 million together with its affiliates, in the debt and equity of portfolio company Halt Medical, Inc., a medical device company focused on women's health.   "American Capital is pleased to be supporting our portfolio company Halt Medical as it continues to grow its medical device business focused on treating uterine fibroids," said Gordon O'Brien, American Capital President, Specialty Finance and Operations.  "Our additional investment will support the company as it moves forward with obtaining FDA approval for the surgical use of its products and the commercialization of its products for use in major ...

Watson Announces Initiation of Esmya(R) U.S. Phase 3 Clinical Trial
PARSIPPANY, N.J., March 12, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced it has initiated its Phase 3 trial to evaluate the efficacy and safety of Esmya® (ulipristal acetate) in women with anemia associated with uterine leiomyomas, a medical condition often referred to as uterine fibroids (myomas).  Leiomyomata are benign solid tumors that often lead to excessive menstrual bleeding, anemia and pain, which ultimately may require surgical intervention.  "Initiation of the U.S.